Navigation Links
'Swine Flu' Shot May Be Cleared of Guillain-Barre Charges
Date:7/13/2011

WEDNESDAY, July 13 (HealthDay News) -- A new European study finds that the supercharged vaccines used to fight the H1N1 epidemic in 2009 may not have boosted the risk for a disease known as Guillain-Barre syndrome after all.

Guillain-Barre is a rare disorder, which causes a person's immune system to damage nerve cells, resulting in muscle weakness and even paralysis.

In 1976, a vaccine used during a U.S. flu outbreak was linked to the disease, and the government halted vaccination. Debate has continued since then over whether vaccines in use could trigger the syndrome.

In a study published July 13 in the journal BMJ, a consortium of researchers reported that the H1N1 vaccine posed little, if any, increased risk for the disease.

"This study provides reassurance that adjuvanted pandemic influenza A (H1N1) 2009 vaccines did not increase the risk of Guillain-Barre syndrome substantially, if at all," they wrote in a journal news release.

Their conclusion stemmed from an analysis of 50 million people in five European countries that vaccinated people against H1N1 in 2009. The researchers compared 104 people with Guillain-Barre syndrome or a related condition to other people without the diseases.

The researchers adjusted their statistics to account for other risk factors for the diseases and found no link between flu vaccination and Guillain-Barre syndrome. Still, noting that it's possible a small risk might remain, they estimated there may be less than three extra cases of Guillain-Barre syndrome for each one million people who get protected by a flu vaccination.

Larger studies already in progress should provide even more definitive information, the study authors added.

More information

For more about flu vaccination, visit the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCE: BMJ, news release, July 12, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Swine flu spread was much wider than first thought, scientists say
2. Tracking Swine Flu Virus in Pigs Reveals Mutations
3. A Year After Its Emergence, H1N1 Swine Flu Lingers
4. Officials See Uptick in H1N1 Swine Flu Cases
5. Swine Flu vaccination: voluntary system works
6. 96 percent of vasectomy patients cleared without need for multiple semen samples
7. Guillain-Barre Syndrome Very Rare After H1N1 Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Swine Flu' Shot May Be Cleared of Guillain-Barre Charges
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
Breaking Medicine Technology: